@article{f1b1a6c9cb824fb199fe768a3040a492,
title = "Innovative add-on treatments for schizophrenia",
author = "Buckley, {Peter F.} and Miller, {Brian J.}",
note = "Funding Information: Disclosure: Peter F. Buckley receives funding for immunological clinical trials in schizophrenia from the Stanley Medical Research Institute and the Brain and Behavior Research Foundation. Brian J. Miller discloses a salary from Augusta University; grants from Augusta University, the Brain & Behavior Research Foundation, the National Institute of Mental Health, and the Stanley Medical Research Institute; consultant for Psychiatric Times; and contracted research for Alkermes and Sunovion. doi:10.3928/00485713-20180411-03",
year = "2018",
month = may,
doi = "10.3928/00485713-20180411-03",
language = "English (US)",
volume = "48",
pages = "208--209",
journal = "Psychiatric Annals",
issn = "0048-5713",
publisher = "Slack Incorporated",
number = "5",
}
